{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T05:02:53Z","timestamp":1768885373854,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007128","name":"Natural Science Foundation of Shaanxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017614","name":"Xi'an Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.taap.2021.115420","type":"journal-article","created":{"date-parts":[[2021,1,24]],"date-time":"2021-01-24T17:45:43Z","timestamp":1611510343000},"page":"115420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Sorafenib not only impairs endothelium-dependent relaxation but also promotes vasoconstriction through the upregulation of vasoconstrictive endothelin type B receptors"],"prefix":"10.1016","volume":"414","author":[{"given":"Qi","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andong","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengqian","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenhao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Lian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cangbao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2021.115420_bb0005","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.jjcc.2009.03.009","article-title":"Sorafenib-induced acute myocardial infarction due to coronary artery spasm","volume":"54","author":"Arima","year":"2009","journal-title":"J. Cardiol."},{"key":"10.1016\/j.taap.2021.115420_bb0010","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.tcm.2012.09.008","article-title":"Cardiovascular complications associated with novel angiogenesis inhibitors: emerging evidence and evolving perspectives","volume":"23","author":"Bair","year":"2013","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.taap.2021.115420_bb0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11936-016-0452-z","article-title":"Anti-VEGF-induced hypertension: a review of pathophysiology and treatment options","volume":"18","author":"Brinda","year":"2016","journal-title":"Curr. Treat Options Cardiovasc. Med."},{"key":"10.1016\/j.taap.2021.115420_bb0020","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1161\/ATVBAHA.113.301938","article-title":"Metformin protects endothelial function in diet-induced obese mice by inhibition of endoplasmic reticulum stress through 5\u2032 adenosine monophosphate-activated protein kinase-peroxisome proliferator-activated receptor delta pathway","volume":"34","author":"Cheang","year":"2014","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.taap.2021.115420_bb0025","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1471-2121-10-52","article-title":"Role of ERK\/MAPK in endothelin receptor signaling in human aortic smooth muscle cells","volume":"10","author":"Chen","year":"2009","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.taap.2021.115420_bb0030","doi-asserted-by":"crossref","first-page":"22976","DOI":"10.1038\/srep22976","article-title":"Activation of c-Jun predicts a poor response to sorafenib in hepatocellular carcinoma: Preliminary Clinical Evidence","volume":"6","author":"Chen","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2021.115420_bb0035","doi-asserted-by":"crossref","first-page":"44123","DOI":"10.1038\/srep44123","article-title":"Overcoming sorafenib evasion in hepatocellular carcinoma using CXCR4-targeted nanoparticles to co-deliver MEK-inhibitors","volume":"7","author":"Chen","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2021.115420_bb0040","first-page":"5229","article-title":"Role of endothelin1 and its receptors in cerebral vasospasm following subarachnoid hemorrhage","volume":"18","author":"Cheng","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2021.115420_bb0045","doi-asserted-by":"crossref","first-page":"7143","DOI":"10.2147\/OTT.S176903","article-title":"Tumoral response and tumoral phenotypic changes in a rat model of diethylnitrosamine-induced hepatocellular carcinoma after salirasib and sorafenib administration","volume":"11","author":"Ciccarelli","year":"2018","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.taap.2021.115420_bb0050","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1038\/s41569-019-0176-3","article-title":"Endothelins in cardiovascular biology and therapeutics","volume":"16","author":"Dhaun","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.taap.2021.115420_bb0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2016.11.174","article-title":"Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond","volume":"227","author":"Di Lisi","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.taap.2021.115420_bb0060","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aau1165","article-title":"Convergence of VEGF and YAP\/TAZ signaling: implications for angiogenesis and cancer biology","volume":"11","author":"Elaimy","year":"2018","journal-title":"Sci. Signal."},{"key":"10.1016\/j.taap.2021.115420_bb0065","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1161\/01.ATV.0000217611.81085.c5","article-title":"Endothelium-derived hyperpolarizing factor: where are we now?","volume":"26","author":"Feletou","year":"2006","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.taap.2021.115420_bb0070","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cytogfr.2009.11.003","article-title":"Pathways mediating VEGF-independent tumor angiogenesis","volume":"21","author":"Ferrara","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.taap.2021.115420_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/CAD.0000000000000316","article-title":"Sorafenib induces autophagic cell death and apoptosis in hepatic stellate cell through the JNK and Akt signaling pathways","volume":"27","author":"Hao","year":"2016","journal-title":"Anti-Cancer Drugs"},{"key":"10.1016\/j.taap.2021.115420_bb0080","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1158\/1078-0432.CCR-09-1717","article-title":"Rapid development of hypertension by sorafenib: toxicity or target?","volume":"15","author":"Humphreys","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.taap.2021.115420_bb0085","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/HJH.0b013e32835c1d1b","article-title":"Mechanism of hypertension and proteinuria during angiogenesis inhibition: evolving role of endothelin-1","volume":"31","author":"Lankhorst","year":"2013","journal-title":"J. Hypertens."},{"key":"10.1016\/j.taap.2021.115420_bb0090","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bcpt.12365","article-title":"The adverse effects of sorafenib in patients with advanced cancers","volume":"116","author":"Li","year":"2015","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.taap.2021.115420_bb0095","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/s41422-020-0309-6","article-title":"s-HBEGF\/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide","volume":"30","author":"Luo","year":"2020","journal-title":"Cell Res."},{"key":"10.1016\/j.taap.2021.115420_bb0100","first-page":"435132","article-title":"The role of uridine adenosine tetraphosphate in the vascular system","volume":"2011","author":"Matsumoto","year":"2011","journal-title":"Adv. Pharmacol. Sci."},{"key":"10.1016\/j.taap.2021.115420_bb0105","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1248\/bpb.b19-00177","article-title":"Direct impairment of the endothelial function by acute Indoxyl sulfate through declined nitric oxide and not endothelium-derived hyperpolarizing factor or vasodilator prostaglandins in the rat superior mesenteric artery","volume":"42","author":"Matsumoto","year":"2019","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.taap.2021.115420_bb0110","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1056\/NEJMra1100265","article-title":"Cardiovascular toxic effects of targeted cancer therapies","volume":"375","author":"Moslehi","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.taap.2021.115420_bb0115","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.mri.2018.11.012","article-title":"Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma","volume":"57","author":"Munoz","year":"2019","journal-title":"Magn. Reson. Imaging"},{"key":"10.1016\/j.taap.2021.115420_bb0120","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.2353\/ajpath.2006.050711","article-title":"Inhibition of tumor endothelial ERK activation, angiogenesis, and tumor growth by sorafenib (BAY43-9006)","volume":"169","author":"Murphy","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2021.115420_bb0125","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s00059-011-3444-5","article-title":"Sorafenib-associated multivessel coronary artery vasospasm","volume":"36","author":"Naib","year":"2011","journal-title":"Herz"},{"key":"10.1016\/j.taap.2021.115420_bb0130","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1011464510857","article-title":"Endothelin and heart failure","volume":"6","author":"Nambi","year":"2001","journal-title":"Heart Fail. Rev."},{"key":"10.1016\/j.taap.2021.115420_bb0135","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/HYPERTENSIONAHA.117.10271","article-title":"Mechanisms of VEGF (vascular endothelial growth factor) inhibitor-associated hypertension and vascular disease","volume":"71","author":"Pandey","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.taap.2021.115420_bb0140","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3892\/ijo.2014.2252","article-title":"ROS-mediated JNK\/p38-MAPK activation regulates Bax translocation in Sorafenib-induced apoptosis of EBV-transformed B cells","volume":"44","author":"Park","year":"2014","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.taap.2021.115420_bb0145","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/hep.25872","article-title":"Cyclic AMP\/PKA-dependent paradoxical activation of Raf\/MEK\/ERK signaling in polycystin-2 defective mice treated with sorafenib","volume":"56","author":"Spirli","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.taap.2021.115420_bb0150","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1634\/theoncologist.12-4-426","article-title":"Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors","volume":"12","author":"Strumberg","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/j.taap.2021.115420_bb0155","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.4103\/1673-5374.285006","article-title":"Neuroprotective effects of ZL006 in Abeta1-42-treated neuronal cells","volume":"15","author":"Tao","year":"2020","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.taap.2021.115420_bb0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jash.2018.03.008","article-title":"Vascular toxicities with VEGF inhibitor therapies-focus on hypertension and arterial thrombotic events","volume":"12","author":"Touyz","year":"2018","journal-title":"J. Am. Soc. Hypertens"},{"key":"10.1016\/j.taap.2021.115420_bb0165","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nrd2130","article-title":"Discovery and development of sorafenib: a multikinase inhibitor for treating cancer","volume":"5","author":"Wilhelm","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.taap.2021.115420_bb0170","doi-asserted-by":"crossref","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","article-title":"Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling","volume":"7","author":"Wilhelm","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.taap.2021.115420_bb0175","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pharmthera.2010.04.013","article-title":"Cardiovascular risk factors regulate the expression of vascular endothelin receptors","volume":"127","author":"Xu","year":"2010","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2021.115420_bb0180","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.vph.2013.11.004","article-title":"Low density lipoprotein induces upregulation of vasoconstrictive endothelin type B receptor expression","volume":"60","author":"Xu","year":"2014","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.taap.2021.115420_bb0185","first-page":"2780","article-title":"Shortterm use of atorvastatin affects glucose homeostasis and suppresses the expression of LDL receptors in the pancreas of mice","volume":"18","author":"Yu","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.taap.2021.115420_bb0190","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.atherosclerosis.2007.06.031","article-title":"Up-regulation of thromboxane A2 receptor expression by lipid soluble smoking particles through post-transcriptional mechanisms","volume":"196","author":"Zhang","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.taap.2021.115420_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejphar.2014.01.008","article-title":"Apolipoprotein B of low-density lipoprotein impairs nitric oxide-mediated endothelium-dependent relaxation in rat mesenteric arteries","volume":"725","author":"Zhang","year":"2014","journal-title":"Eur. J. Pharmacol."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X21000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:52:54Z","timestamp":1758574374000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X21000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":39,"alternative-id":["S0041008X21000272"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2021.115420","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sorafenib not only impairs endothelium-dependent relaxation but also promotes vasoconstriction through the upregulation of vasoconstrictive endothelin type B receptors","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2021.115420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115420"}}